Sinem Namdaroğlu

The outcome of COVID‐19 in patients with hematological malignancy

Tuğçe Nur Yiğenoğlu, Naim Ata, Fevzi Altuntaş et al. · Journal of Medical Virology · 2020 · 129 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Intensive Care Unit +15

Convalescent plasma therapy in patients with COVID-19

Fevzi Altuntaş, Naim Ata, Tuğçe Nur Yiğenoğlu et al. · Transfusion and Apheresis Science · 2020 · 65 citations · Full text

Covid-19 Pandemic, Convalescent Plasma Therapy, Covid-19 Epidemiology +3

Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Semih Başçı, Naim Ata, Fevzi Altuntaş et al. · Journal of Oncology Pharmacy Practice · 2020 · 40 citations · Full text

Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?

Emre Tekgündüz, Ali Kaya, Sinem Civriz Bozdağ et al. · Transfusion and Apheresis Science · 2016 · 19 citations

Transplantation, Stem Cell Transplantation, Hematology +7

Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

Semih Başçı, Naim Ata, Fevzi Altuntaş et al. · Internal and Emergency Medicine · 2021 · 19 citations · Full text

Hematological Malignancy, Cancer-associated Virus, Solid Cancers +11